1. 794 Safety and efficacy results from a phase 1/1b study of intratumoral MK-4621, a retinoic acid-inducible gene I (RIG-I) agonist, plus intravenous pembrolizumab in patients with advanced solid tumors. (10th December 2020) Authors: Moreno, Victor; Gaudy-Marqueste, Caroline; Wermke, Martin; Italiano, Antoine; Romano, Emanuela; Marabelle, Aurelien; Connors, Emilee; Zhou, Heng; Dobrenkov, Konstantin; Chartash, Elliot; Calvo, Emiliano; Aller, Emiliano Calvo Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A474 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Diabetes and Blood Glucose Disorders Under Anti-PD1. Issue 5 (June 2018) Authors: Magis, Quentin; Gaudy-Marqueste, Caroline; Basire, Agnes; Loundou, Anderson; Malissen, Nausicaa; Troin, Laura; Monestier, Sandrine; Mallet, Stéphanie; Hesse, Sylvie; Richard, Marie-Aleth; Valéro, René; Beliard, Sophie; Grob, Jean-Jacques Journal: Journal of immunotherapy Issue: Volume 41:Issue 5(2018:Jun.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Efficacy of Immunotherapy in Patients with Metastatic Mucosal or Uveal Melanoma. (2nd December 2018) Authors: Mignard, Claire; Deschamps Huvier, Aurélie; Gillibert, André; Duval Modeste, Anne Bénédicte; Dutriaux, Caroline; Khammari, Amir; Avril, Marie-Françoise; Kramkimel, Nora; Mortier, Laurent; Marcant, Pierre; Lesimple, Thierry; Gaudy-Marqueste, Caroline; Lesage, Candice; Machet, Laurent; Aubin, Franç... Other Names: Mulshine James L. Academic Editor. Journal: Journal of oncology Issue: Volume 2018(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. HVEM has a broader expression than PD-L1 and constitutes a negative prognostic marker and potential treatment target for melanoma. (2nd December 2019) Authors: Malissen, Nausicaa; Macagno, Nicolas; Granjeaud, Samuel; Granier, Clémence; Moutardier, Vincent; Gaudy-Marqueste, Caroline; Habel, Nadia; Mandavit, Marion; Guillot, Bernard; Pasero, Christine; Tartour, Eric; Ballotti, Robert; Grob, Jean-Jacques; Olive, Daniel Journal: Oncoimmunology Issue: Volume 8:Number 12(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Immune checkpoints inhibitors for solid tumours after allogeneic haematopoietic stem-cell transplantation: About four clinical cases. (August 2017) Authors: Monneur, Audrey; Monnier, Jilliana; Gaudy-Marqueste, Caroline; Devillier, Raynier; Sabatier, Renaud Journal: European journal of cancer Issue: Volume 81(2017) Page Start: 138 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. LBR mutation and nuclear envelope defects in a patient affected with Reynolds syndrome. Issue 6 (3rd June 2010) Authors: Gaudy-Marqueste, Caroline; Roll, Patrice; Esteves-Vieira, Vera; Weiller, Pierre-Jean; Grob, Jean Jacques; Cau, Pierre; Lévy, Nicolas; De Sandre-Giovannoli, Annachiara Journal: Journal of medical genetics Issue: Volume 47:Issue 6(2010) Page Start: 361 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Macrophage activation syndrome: A new complication of checkpoint inhibitors. (May 2017) Authors: Malissen, Nausicaa; Lacotte, Julie; Du-Thanh, Aurélie; Gaudy-Marqueste, Caroline; Guillot, Bernard; Grob, Jean-Jacques Journal: European journal of cancer Issue: Volume 77(2017) Page Start: 88 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Mogamulizumab in a patient with Sézary syndrome and severe atopic dermatitis. (October 2021) Authors: Amatore, Florent; Connell, Emily; Aymonier, Marie; Gaudy-Marqueste, Caroline; Richard, Marie-Aleth Journal: European journal of cancer Issue: Volume 156(2021)Supplement 1 Page Start: S51 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Safety and immunogenicity after 2 doses of the BNT162b2 COVID-19 vaccine in an early-phase oncology trial centre population. (October 2021) Authors: Malissen, Nausicaa; Ninove, Laetitia; de Lamballerie, Xavier; André, Nicolas; Gaudy-Marqueste, Caroline Journal: European journal of cancer Issue: Volume 156(2021) Page Start: 125 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Stereotactic radiosurgery combined with anti-PD1 for the management of melanoma brain metastases: A retrospective study of safety and efficacy. (August 2020) Authors: Carron, Romain; Gaudy-Marqueste, Caroline; Amatore, Florent; Padovani, Laetitia; Malissen, Nausicaa; Balossier, Anne; Loundou, Anderson; Bonnet, Nathalie; Muracciole, Xavier; Régis, Jean-Marie; Grob, Jean-Jacques Journal: European journal of cancer Issue: Volume 135(2020) Page Start: 52 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗